NCT06405750View on ClinicalTrials.gov

Left Atrial Appendage Arrhythmogenic and Thrombogenic Substrate

NARecruitingINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

December 31, 2035

Study Completion Date

December 31, 2035

Conditions
Atrial FibrillationStroke
Interventions
PROCEDURE

left atrial appendage closure

systematic closure of the left atrial appendage in addition to the planned heart surgery

Trial Locations (1)

Unknown

RECRUITING

Rigshospitalet, Copenhagen

All Listed Sponsors
collaborator

Rigshospitalet, Denmark

OTHER

collaborator

University of Copenhagen

OTHER

lead

University Hospital Bispebjerg and Frederiksberg

OTHER

NCT06405750 - Left Atrial Appendage Arrhythmogenic and Thrombogenic Substrate | Biotech Hunter | Biotech Hunter